Chosa Oncology

Chosa Oncology is a company listed under the stock ticker RHOVAC (SE).

View the org chart displaying its 9 main executives

Most searched biographies at Chosa Oncology

• Peter Buhl, Chief Executive Officer
• Claus Pedersen, Director
• Ingrid Atteryd Heiman, Director

Popular executive movements at Chosa Oncology

• Gerton Jönsson has joined the company as Chief Financial Officer  (posted on March 30 2024).

Create your alert
to follow the executive moves at Chosa Oncology.

Chosa Oncology has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Chosa Oncology

Social media about Chosa Oncology

• Chosa Oncology on Wikipedia, Google News & Yahoo Finance
• Chosa Oncology on LinkedIn, Twitter & YouTube

Contact by email its executives including Peter Buhl

Call Chosa Oncology at +46 73...

View the org chart

Register to receive your alert

Report an error